Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 4
2006 1
2007 2
2008 1
2009 2
2010 4
2011 3
2012 1
2013 2
2014 1
2015 2
2016 3
2017 2
2018 3
2019 4
2020 2
2021 5
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
IBD barriers across the continents: a continent-specific analysis - Australasia.
Elford AT, Leong RW, Halmos EP, Morgan M, Kilpatrick K, Lewindon PJ, Gearry RB, Christensen B. Elford AT, et al. Among authors: lewindon pj. Therap Adv Gastroenterol. 2023 Sep 8;16:17562848231197509. doi: 10.1177/17562848231197509. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37701793 Free PMC article. Review.
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
Crowley E, Ma C, Guizzetti L, Zou G, Lewindon PJ, Gee MS, Hyams JS, Rosen MJ, von Allmen D, de Buck van Overstraeten A, Shackelton LM, Remillard J, Schleicher L, Dillman JR, Rimola J, Taylor SA, Fletcher JG, Church PC, Feagan BG, Griffiths AM, Jairath V, Greer MC. Crowley E, et al. Among authors: lewindon pj. Inflamm Bowel Dis. 2024 Mar 1;30(3):357-369. doi: 10.1093/ibd/izad134. Inflamm Bowel Dis. 2024. PMID: 37524088 Review.
Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.
Colombo C, Ramm GA, Lindblad A, Corti F, Porcaro L, Alghisi F, Asherova I, Evans H, Kashirskaya N, Kondratyeva E, Lewindon PJ, de Monestrol I, Oliver M, Ooi CY, Padoan R, Shankar S, Alicandro G. Colombo C, et al. Among authors: lewindon pj. J Cyst Fibros. 2023 Mar;22(2):263-265. doi: 10.1016/j.jcf.2023.01.012. Epub 2023 Feb 2. J Cyst Fibros. 2023. PMID: 36739240
SARS-CoV-2 vaccination in patients with inflammatory bowel disease.
Prentice RE, Rentsch C, Al-Ani AH, Zhang E, Johnson D, Halliday J, Bryant R, Begun J, Ward MG, Lewindon PJ, Connor SJ, Ghaly S, Christensen B. Prentice RE, et al. Among authors: lewindon pj. GastroHep. 2021 Jul;3(4):212-228. doi: 10.1002/ygh2.473. Epub 2021 Jul 23. GastroHep. 2021. PMID: 34539248 Free PMC article. Review.
Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study.
Colombo C, Alicandro G, Oliver M, Lewindon PJ, Ramm GA, Ooi CY, Alghisi F, Kashirskaya N, Kondratyeva E, Corti F, Padoan R, Asherova I, Evans H, de Monestrol I, Strandvik B, Lindblad A; CF UDCA study group. Colombo C, et al. Among authors: lewindon pj. J Cyst Fibros. 2022 Mar;21(2):220-226. doi: 10.1016/j.jcf.2021.03.014. Epub 2021 Apr 2. J Cyst Fibros. 2022. PMID: 33814323 Free article.
Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease.
Goodsall TM, Jairath V, Feagan BG, Parker CE, Nguyen TM, Guizzetti L, Asthana AK, Begun J, Christensen B, Friedman AB, Kucharzik T, Lee A, Lewindon PJ, Maaser C, Novak KL, Rimola J, Taylor KM, Taylor SA, White LS, Wilkens R, Wilson SR, Wright EK, Bryant RV, Ma C. Goodsall TM, et al. Among authors: lewindon pj. Aliment Pharmacol Ther. 2021 Apr;53(8):873-886. doi: 10.1111/apt.16288. Epub 2021 Feb 28. Aliment Pharmacol Ther. 2021. PMID: 33641221
42 results